CDXS - Codexis, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $0.01
|
Rev Est: $35.8M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$11.00
DETAILS
HIGH:
$11.00
LOW:
$11.00
MEDIAN:
$11.00
CONSENSUS:
$11.00
UPSIDE:
895.48%
Market Cap:
99.81M
Volume:
1,655,314
Avg Volume:
1,062,993
52 Week Range:
1.09-4.3
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.47
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
188
IPO Date:
2010-04-22
EPS (TTM):
-0.89
P/E Ratio:
-5.36
Revenue (TTM):
59.34M
Total Assets:
149.01M
Total Debt:
59.90M
Cash & Equiv:
19.26M
Rev Growth (5Y):
-2.8%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-46.5%
Debt/Equity:
0.89
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.22 | $-0.15 | -46.7% | $8.6M | $35.8M | -76.0% |
| 2025-08-13 | $-0.16 | $-0.17 | +5.9% | $15.3M | $19.5M | -21.3% |
| 2025-05-14 | $-0.25 | $-0.20 | -25.0% | $7.5M | $9.7M | -21.9% |
| 2025-02-27 | $-0.13 | $-0.04 | -225.0% | $21.5M | $27.4M | -21.7% |
| 2024-10-31 | $-0.29 | $-0.25 | -16.0% | $12.8M | $27.4M | -53.2% |
| 2024-08-08 | $-0.32 | $-0.26 | -23.1% | $8.0M | $7.8M | +2.0% |
| 2024-05-02 | $-0.16 | $-0.17 | +5.9% | $17.1M | $13.7M | +25.0% |
| 2024-02-28 | $0.02 | $-0.16 | +112.5% | $26.6M | $19.9M | +33.5% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 59.34M | 70.14M | 138.59M | 104.75M | 69.06M | 68.46M | 60.59M | 50.02M | 48.84M | 41.80M | 35.31M | 31.92M |
| Net Income | (65.28M) | (76.24M) | (33.59M) | (21.28M) | (24.01M) | (11.94M) | (10.88M) | (23.00M) | (8.56M) | (7.58M) | (19.07M) | (41.30M) |
| EPS | -0.89 | -1.12 | -0.51 | -0.33 | -0.40 | -0.21 | -0.21 | -0.50 | -0.21 | -0.19 | -0.50 | -1.08 |
| Total Assets | 149.01M | 136.56M | 250.39M | 246.38M | 221.65M | 149.07M | 78.28M | 53.62M | 35.65M | 44.65M | 48.12M | 58.84M |
| Total Debt | 59.90M | 16.02M | 43.64M | 47.65M | 24.95M | 26.12M | 61,000 | 302,000 | 425,000 | 425,000 | 0 | 0 |
| Cash & Equivalents | 19.26M | 65.12M | 113.98M | 116.80M | 149.12M | 90.50M | 53.04M | 31.22M | 19.24M | 23.27M | 26.49M | 22.13M |
| Operating Cash Flow | (49.41M) | (52.64M) | 11.28M | (14.27M) | (16.46M) | (12.56M) | (14.09M) | (8.76M) | (2.70M) | (433,000) | 321,000 | (23.00M) |
| Free Cash Flow | (53.72M) | (57.06M) | 2.98M | (28.09M) | (20.21M) | (16.29M) | (16.86M) | (9.75M) | (3.59M) | (1.63M) | 19,000 | (24.17M) |
| FCF per Share | -0.73 | -0.84 | 0.05 | -0.44 | -0.34 | -0.29 | -0.32 | -0.21 | -0.09 | -0.04 | 0.00 | -0.63 |
| Book Value | 66.93M | 86.61M | 144.80M | 164.39M | 170.10M | 105.52M | 56.31M | 24.55M | 19.10M | 22.88M | 26.31M | 41.48M |
| Cash & ST Investments | 73.46M | 65.12M | 113.98M | 116.80M | 150.12M | 90.50M | 53.04M | 31.22M | 19.24M | 23.27M | 26.49M | 25.14M |
| ROC Equity | -0.98 | -0.88 | -0.23 | -0.13 | -0.14 | -0.11 | -0.19 | -0.94 | -0.45 | -0.33 | -0.72 | -1.00 |